Designing oversight for nanomedicine research in human subjects: systematic analysis of exceptional oversight for emerging technologies

Multicriteria mapping of stakeholder preferences in regulating nanotechnology

(2010) Steffen Foss Hansen   JOURNAL OF NANOPARTICLE RESEARCH

Don't Mess with the DSMB

(2010) Jeffrey M. Drazen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications

(2009) Bengt Fadeel et al.   ADVANCED DRUG DELIVERY REVIEWS

Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?

(2009) Peter Hoet et al.   DRUG SAFETY

Strengthening Institutional Review Board Review of Highly Innovative Interventions in Clinical Trials

(2009) Bernard Lo   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Challenge of Developing Oversight Approaches to Nanobiotechnology

(2009) Jordan Paradise et al.   JOURNAL OF LAW MEDICINE & ETHICS

Empirical Analysis of Current Approaches to Incidental Findings

(2008) Frances Lawrenz et al.   JOURNAL OF LAW MEDICINE & ETHICS

Nanotechnology: The coming revolution and its implications for consumers, clinicians, and informatics

(2008) Nancy Staggers et al.   NURSING OUTLOOK